Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Oct;110(2):719–723. doi: 10.1111/j.1476-5381.1993.tb13871.x

Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.

M Y Farhat 1, M F Chen 1, T Bhatti 1, A Iqbal 1, S Cathapermal 1, P W Ramwell 1
PMCID: PMC2175952  PMID: 8242243

Abstract

1. We studied the effects of oestradiol 17 beta on the development of pulmonary vascular changes and right ventricular (RV) hypertrophy in response to monocrotaline in male Sprague-Dawley rats. 2. Rats were treated with either placebo or oestradiol 17 beta (10 mg) in the form of slow release pellets implanted subcutaneously 48 h before monocrotaline administration. Rats were injected with either saline or a single dose of monocrotaline (60 mg kg-1, i.m.). Pulmonary vascular changes and RV hypertrophy were studied at 4 weeks following monocrotaline administration. 3. Monocrotaline induced a significant increase in the ratio of right ventricle (RV) to left ventricle-plus-septum (LV + S) weights. Monocrotaline-treated rats also showed significant myointimal proliferation in small pulmonary arteries, decrease of arterial numbers and increase in the number of abnormal alveolar macrophages. 4. Oestradiol 17 beta attenuated myointimal hyperplasia in pulmonary vessels, decreased the RV/(LV + S) ratio in monocrotaline-treated rats. Oestradiol 17 beta had no significant effect on control animals. 5. Oestradiol treatment prevented the increase in lung wet to dry weight ratio, observed 7 days post monocrotaline administration. 6. These results suggest that oestradiol 17 beta protects against the pulmonary vascular remodelling and RV hypertrophy associated with monocrotaline-induced pulmonary hypertension in the rat. Oestradiol also protects against microvascular leak observed in the early days of lesion.

Full text

PDF
719

Images in this article

721Figure 2
on p.721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boorman G. A., Luster M. I., Dean J. H., Wilson R. E. The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J Reticuloendothel Soc. 1980 Dec;28(6):547–560. [PubMed] [Google Scholar]
  2. Butler W. H. An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloids. J Pathol. 1970 Sep;102(1):15–19. doi: 10.1002/path.1711020104. [DOI] [PubMed] [Google Scholar]
  3. Chan C. C., Kalsner S. Termination of responses to sympathetic nerve stimulation and to noradrenaline in a perfused arterial preparation: the role of neuronal and extraneuronal uptake. J Pharmacol Exp Ther. 1982 Sep;222(3):731–740. [PubMed] [Google Scholar]
  4. Colucci W. S., Gimbrone M. A., Jr, McLaughlin M. K., Halpern W., Alexander R. W. Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res. 1982 Jun;50(6):805–811. doi: 10.1161/01.res.50.6.805. [DOI] [PubMed] [Google Scholar]
  5. FULTON R. M., HUTCHINSON E. C., JONES A. M. Ventricular weight in cardiac hypertrophy. Br Heart J. 1952 Jul;14(3):413–420. doi: 10.1136/hrt.14.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farhat M. Y., Ramwell P. W. Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619. J Pharmacol Exp Ther. 1992 May;261(2):686–691. [PubMed] [Google Scholar]
  7. Farhat M. Y., Vargas R., Dingaan B., Ramwell P. W. In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol. 1992 Nov;107(3):679–683. doi: 10.1111/j.1476-5381.1992.tb14506.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fischer G. M., Swain M. L. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 1985 Feb;54(2):177–185. doi: 10.1016/0021-9150(85)90177-7. [DOI] [PubMed] [Google Scholar]
  9. Foegh M. L., Khirabadi B. S., Nakanishi T., Vargas R., Ramwell P. W. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc. 1987 Aug;19(4 Suppl 5):90–95. [PubMed] [Google Scholar]
  10. Fuchs K. I., Moore L. G., Rounds S. Pulmonary vascular reactivity is blunted in pregnant rats. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):703–707. doi: 10.1152/jappl.1982.53.3.703. [DOI] [PubMed] [Google Scholar]
  11. Ghodsi F., Will J. A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol. 1981 Feb;240(2):H149–H155. doi: 10.1152/ajpheart.1981.240.2.H149. [DOI] [PubMed] [Google Scholar]
  12. Gordon J. B., Wetzel R. C., McGeady M. L., Adkinson N. F., Jr, Sylvester J. T. Effects of indomethacin on estradiol-induced attenuation of hypoxic vasoconstriction in lamb lungs. J Appl Physiol (1985) 1986 Dec;61(6):2116–2121. doi: 10.1152/jappl.1986.61.6.2116. [DOI] [PubMed] [Google Scholar]
  13. Hayashi Y., Hussa J. F., Lalich J. J. Cor pulmonale in rats. Lab Invest. 1967 Jun;16(6):875–881. [PubMed] [Google Scholar]
  14. Hilliker K. S., Bell T. G., Roth R. A. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs. Thromb Haemost. 1983 Dec 30;50(4):844–847. [PubMed] [Google Scholar]
  15. Ito K., Nakashima T., Murakami K., Murakami T. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats. Br J Pharmacol. 1988 Aug;94(4):1175–1183. doi: 10.1111/j.1476-5381.1988.tb11636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jurjens H., Pratt J. J., Woldring M. G. Radioimmunoassay of plasma estradiol without extraction and chromatography. J Clin Endocrinol Metab. 1975 Jan;40(1):19–25. doi: 10.1210/jcem-40-1-19. [DOI] [PubMed] [Google Scholar]
  17. Khosla S. S., Smith G. J., Parks P. A., Rooney S. A. Effects of estrogen on fetal rabbit lung maturation: morphological and biochemical studies. Pediatr Res. 1981 Sep;15(9):1274–1281. doi: 10.1203/00006450-198109000-00010. [DOI] [PubMed] [Google Scholar]
  18. Kushwaha R. S., Hazzard W. R. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 1981 Apr;30(4):359–366. doi: 10.1016/0026-0495(81)90116-5. [DOI] [PubMed] [Google Scholar]
  19. Loose L. D., DiLuzio N. R. Dose-related reticuloendothelial system stimulation by diethylstilbestrol. J Reticuloendothel Soc. 1976 Dec;20(6):457–460. [PubMed] [Google Scholar]
  20. Meyrick B. O., Reid L. M. Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am J Pathol. 1982 Jan;106(1):84–94. [PMC free article] [PubMed] [Google Scholar]
  21. Meyrick B., Gamble W., Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol. 1980 Nov;239(5):H692–H702. doi: 10.1152/ajpheart.1980.239.5.H692. [DOI] [PubMed] [Google Scholar]
  22. Moore L. G., Reeves J. T. Pregnancy blunts pulmonary vascular reactivity in dogs. Am J Physiol. 1980 Sep;239(3):H297–H301. doi: 10.1152/ajpheart.1980.239.3.H297. [DOI] [PubMed] [Google Scholar]
  23. Ono S., Voelkel N. F. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J Appl Physiol (1985) 1991 Dec;71(6):2483–2492. doi: 10.1152/jappl.1991.71.6.2483. [DOI] [PubMed] [Google Scholar]
  24. Ono S., Voelkel N. F. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. Lung. 1992;170(1):31–40. doi: 10.1007/BF00164753. [DOI] [PubMed] [Google Scholar]
  25. Osborne C. K., Hobbs K., Clark G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 1985 Feb;45(2):584–590. [PubMed] [Google Scholar]
  26. Plestina R., Stoner H. B. Pulmonary oedema in rats given monocrotaline pyrrole. J Pathol. 1972 Apr;106(4):235–249. doi: 10.1002/path.1711060405. [DOI] [PubMed] [Google Scholar]
  27. Reindel J. F., Ganey P. E., Wagner J. G., Slocombe R. F., Roth R. A. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol Appl Pharmacol. 1990 Nov;106(2):179–200. doi: 10.1016/0041-008x(90)90239-q. [DOI] [PubMed] [Google Scholar]
  28. Resnik R. The endocrine regulation of uterine blood flow in the nonpregnant uterus: a review. Am J Obstet Gynecol. 1981 May 15;140(2):151–156. doi: 10.1016/0002-9378(81)90102-2. [DOI] [PubMed] [Google Scholar]
  29. Rorie D. K., Muldoon S. M. Increased reactivity of isolated rabbit saphenous vein after treatment with estrogen and progesterone. Blood Vessels. 1979;16(5):252–258. doi: 10.1159/000158213. [DOI] [PubMed] [Google Scholar]
  30. Rosenberg H. C., Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988 Dec;255(6 Pt 2):H1484–H1491. doi: 10.1152/ajpheart.1988.255.6.H1484. [DOI] [PubMed] [Google Scholar]
  31. Roth R. A., Reindel J. F. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. Adv Exp Med Biol. 1991;283:477–487. doi: 10.1007/978-1-4684-5877-0_64. [DOI] [PubMed] [Google Scholar]
  32. Schultze A. E., Wagner J. G., White S. M., Roth R. A. Early indications of monocrotaline pyrrole-induced lung injury in rats. Toxicol Appl Pharmacol. 1991 Jun 1;109(1):41–50. doi: 10.1016/0041-008x(91)90189-l. [DOI] [PubMed] [Google Scholar]
  33. Sugita T., Hyers T. M., Dauber I. M., Wagner W. W., McMurtry I. F., Reeves J. T. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol Respir Environ Exerc Physiol. 1983 Feb;54(2):371–374. doi: 10.1152/jappl.1983.54.2.371. [DOI] [PubMed] [Google Scholar]
  34. Sylvester J. T., Gordon J. B., Malamet R. L., Wetzel R. C. Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. Chest. 1985 Oct;88(4 Suppl):252S–254S. doi: 10.1378/chest.88.4_supplement.252s. [DOI] [PubMed] [Google Scholar]
  35. Wetzel R. C., Zacur H. A., Sylvester J. T. Effect of puberty and estradiol on hypoxic vasomotor response in isolated sheep lungs. J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1199–1203. doi: 10.1152/jappl.1984.56.5.1199. [DOI] [PubMed] [Google Scholar]
  36. Williams J. K., Adams M. R., Klopfenstein H. S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990 May;81(5):1680–1687. doi: 10.1161/01.cir.81.5.1680. [DOI] [PubMed] [Google Scholar]
  37. Wolinsky H. Effects of estrogen and progestogen treatment on the response of the aorta of male rats to hypertension. Morphological and chemical studies. Circ Res. 1972 Mar;30(3):341–349. doi: 10.1161/01.res.30.3.341. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES